13 Comments
User's avatar
Donna H's avatar

So Karen, re "PhRMA has forecasted that US Biopharma companies will invest a total of $500 billion into US research and manufacturing" - is this going towards MRNA RESEARCH?

Expand full comment
Karen Kingston's avatar

No. This has nothing to do with mRNA research. It has to do with the BioSecure Act being thwarted and foreign nations forcing US biopharma companies to sell their drugs at cost or a loss to foreign nations.

Expand full comment
Donna H's avatar

Thank you Karen - you have been God's righteous warrior throughout these dark days, as the Enemy of our Souls knows his time is short and wants to keep as many from the Truth as he can (John 14:6). Praying for your strength, that you will continue to be boldly faithful, obedient, and diligent "for such a time as this" (Esther 4:14), and that you will not grow weary (Galatians 6:9-10) - God bless you, dear sister!

Expand full comment
Closed VAERS's avatar

Cool that you mention "Medicaid “Best Price” requirement", that was what the Blood Brothers (LabCorp & Quest) abused and what my old boss used to win a $243M lawsuit against them and became 2011 Whistleblower of the Year (Chris Riedel). I talk a little about it here: https://welcometheeagle.substack.com/p/me-and-maryam-go-together-like-babies.

I'm a bit confused about this situation with reduced prices? For the most part Medicaid patients don't have financial obligation, but may have a Share of Cost (SOC) what people might know as deductible. The SOC structure gets abused because providers would obligate a patient to their cash rate, NOT WHAT MEDICAID WILL REIMBURSE THEM. This is a huge problem and almost a grift within the SOC portion of Medicaid. Medicaid Managed Care also has a co-pay structure but I don't see how the "drug prices" would be advantageous to the patient? Patients will still have the $5,$10,$15,etc. copay for their meds? Maybe thier is some other direct benefit to the patient in the finer print I'm not familiar with anymore... Can't wait to hear you in a upcoming x space. God Bless You KK.

Expand full comment
Karen Kingston's avatar

Hi Albert - By price, I meant cost of the drug, not the co-pay. But if Medicare patients have extremely high co-pays, they may be eligible for a reduced price through the patient assist programs from the industry.

Expand full comment
Karen Kingston's avatar

Hey Albert! I am by no means a payer expert, but having to deal with pricing and financial incentives, I know enough to be dangerous. The Medicaid prices (costs to government) will likely be much lower due to most favored nation pricing - which will likely be reflected as the prices on TrumpRx due to elimination of PBMs. It’s my understanding that if the government is purchasing approximately drugs at a 50-85% discount for 25% of insured Medicaid recipients and these prices are reflected on TrumpRx there are several pathways for state Medicare programs to also negotiate lower pricing.

Expand full comment
John's avatar

I especially like your close, and I echo it in my bedtime prayers and in the mornings to.

And don't forget to bless Uncle Donald too, even if he does sometimes fall short.

Expand full comment
Useless Liberal's avatar

Once you recognize and understand the fraud of their pointless profession you know more than they will ever know.

And you know, by that illuminating insight, that you know more than they all know put together.

Expand full comment
Thomas A Braun RPh's avatar

Unfortunately, what is not understood is that they are bypassing the checks and balances to prevent more harm from drugs being consumed by Americans. They are bypassing, the drug distributors and the retail pharmacist who are the gatekeepers in checking for drug interactions that caused harm and death. It is all about smoking mirrors to maintain big pharmas control over the health of Americans. They sold President Trump the concept because they’re calling it Trump RX and he believes he is doing the right thing but he doesn’t understand the medical dynamics that are in place not for good health but for bottom line profits which will not change for big Pharma companies!

Expand full comment
Thomas A Braun RPh's avatar

My life was saved last November when I got an IV of an antibiotic to stop a massive infection. Everything is not bad, but the problem is they push marginal drugs to keep the bottom line growing.!

Expand full comment
John's avatar

It's been a longl time since I have encountered a competent pharmacist, since the days of the corner drugstore.

The safest route is don't take any of it.

Expand full comment
Science is Political 2.0's avatar

Wow. so that is interesting .. I will go and take a look at that. I so far behind on the computer..I can't believe it.. I heard it too. you are saying that TrumpRX is from medicaid patients.. (federal welfare insurance: that is a good thing.. as long they are Americans. I will look on Rumble. I have Tweak and possibly redo my laptop because the Win11 roll out which is not helping me catch up.. well thanks.

Expand full comment
Karen Kingston's avatar

The pricing on TrumpRx should reflect the costs of drugs purchased by the government for Medicaid patients and drive down the costs for Medicare patients.

Expand full comment